Top

Published in:

01-09-2013 | Original Communication

Genetic association of sirtuin genes and Parkinson’s disease

Authors: Silvia Jesús, Pilar Gómez-Garre, Fátima Carrillo, María T. Cáceres-Redondo, Ismael Huertas-Fernández, Inmaculada Bernal-Bernal, Marta Bonilla-Toribio, Laura Vargas-González, Manuel Carballo, Pablo Mir

Published in: Journal of Neurology | Issue 9/2013

Abstract

Parkinson’s disease (PD) is a neurodegenerative disease caused by both genetic and environmental factors. Sirtuins are highly-conserved, NAD-dependent class III deacetylases that regulate a variety of cellular functions. Most of the known sirtuins have been involved in animal models of neurodegenerative disorders, such as PD. Although seven sirtuin family members have been identified (SIRT1–SIRT7) the relationship between sirtuins and PD in humans has not been established. Our aim was to investigate the association between sirtuin genes and risk of PD. We included 326 PD patients and 371 controls from southern Spain. Forty-one single nucleotide polymorphisms (SNPs) in sirtuin genes were genotyped in order to determine whether they were related to the risk of PD. These SNPs included Tag-SNPs, coding non-synonymous SNPs and SNPs affecting activity of microRNA binding sites. No relationship was found between these SNPs in sirtuin genes and PD. Our data indicate that variations in sirtuin genes do not affect the risk for PD, at least in our population.

Puschman A (2013) Monogenic Parkinson’s disease and parkinsonism: clinical phenotypes and frequencies of known mutations. Parkinsonism Relat Disord 19:407–415CrossRef

Chartier-Harlin MC, Dachsel JC, Vilarino-Guell C et al (2011) Translation initiator EIF4G1 mutations in familial Parkinson disease. Am J Hum Genet 89:398–406PubMedCrossRef

Deng H, Gao K, Jankovic J (2013) The VPS35 gene and Parkinson’s disease. Mov Disord 28(5):569–575PubMedCrossRef

Dali-Youcet N, Lagouge M, Froelich S, Koehl C, Schoonjans K, Auwerx J (2007) Sirtuins: the “magnificent seven”, function, metabolism and longevity. Ann Med 39:335–345CrossRef

Mine JC, Denu JM (2008) The Sirtuin family: therapeutic targets to treat disease of aging. Curr Opin Chem Biol 12:11–17CrossRef

Kim D, Nguyen MD, Dobbin MM et al (2007) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer’s disease and amyotrophic lateral sclerosis. EMBO J 26:3169–3179PubMedCrossRef

Jiang M, Wang J, Fu J et al (2011) Neuroprotective role of Sirt1 in mammalian models of Huntington’s disease through activation of multiple Sirt1 targets. Nat Med 18:153–158PubMedCrossRef

Donmez G, Arun A, Chung CY, McLean PJ, Lindquist S, Guarente L (2012) SIRT1 protects against a-synuclein aggregation by activating molecular chaperones. J Neurosci 32:124–132PubMedCrossRef

Wareski P, Vaarmann A, Choubey V et al (2009) PGC-1a and PGC-1b regulate mitochondrial density in neurons. J Biol Chem 284:21379–21385PubMedCrossRef

10.

Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against cocconi2908 by activating SIRT1 and PGC-1alpha. Cell 127:1109–1122PubMedCrossRef

11.

Della-Morte D, Dave KR, DeFazio RA, Bao YC, Raval AP, Perez-Pinzon MA (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1-uncoupling protein 2 pathway. Neuroscience 159:993–1002PubMedCrossRef

12.

Outeiro TF, Kontopoulos E, Altmann SM et al (2007) Sirtuin 2 inhibitors rescue a-synuclein-mediated toxicity in models of Parkinson’s disease. Science 317:516–519PubMedCrossRef

13.

Liu L, Arun A, Peritore C, Donmez G (2012) Sirtuin 2 (SIRT2) enhances 1-methyl-4-phenyl-1,2,3,6-tetrahidropyridine (MPTP)-induced nigroestriatal damage via deacetylating forehead box O3a (Foxo3a) and activating Bim protein. J Biol Chem 287:32307–32311PubMedCrossRef

14.

Hirschey MD, Shimazu T, Goetzman E et al (2010) SIRT3 regulates fatty acid oxidation via reversible enzyme deacetylation. Nature 582:543–548

15.

Kanfi Y, Shalman R, Peshtia V, Pilosofa SN, Gozlana YM, Pearsonb KJ, Lerrera B, Moazedc D, Marined J-C, Cabob R, Cohena H (2008) Regulation of SIRT6 protein levels by nutrient availability. FEBS Lett 582:543–548PubMedCrossRef

16.

Raghavan A, Shah ZA (2011) Sirtuins in neurodegenerative diseases: a biological–chemical perspective. Neurodegener Dis 9:1–10PubMedCrossRef

17.

Brown K, Xie S, Qiu X et al (2013) SIRT3 reverses aging-associated degeneration. Cell Rep 3:319–327PubMedCrossRef

18.

Kanfi Y, Naiman S, Amir G et al (2012) Sirtuin SIRT6 regulates lifespan in male mice. Nature 483:218–221PubMedCrossRef

19.

Glorioso C, Sunghee O, Douillard GG, Sibille E (2011) Brain molecular aging, promotion of neurological disease and modulation by Sirtuin5 longevity gene polymorphism. Neurobiol Dis 41:279–290PubMedCrossRef

20.

Barber M, Michishita-Kioi E, Xi Y et al (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature 487:114–118PubMed

21.

Gibb WR, Lees AJ (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson’s disease. J Neurol Neurosurg Psychiatry 51:745–752PubMedCrossRef

22.

Purcell S, Neale B, Todd-Brown K et al (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575PubMedCrossRef

23.

Zhang A, Wang H, Qin X, Pang S, Yan B (2012) Genetic analysis of SIRT1 gene promoter in sporadic Parkinson’s disease. Biochem Biophys Res Commun 422:693–696PubMedCrossRef

24.

Cheng HL, Mostoslavsky R, Saito S, Manis JP, Gu Y, Patel P, Bronson R, Appella E, Alt FW, Chua KF (2003) Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA 100:10794–10799PubMedCrossRef

Title: Genetic association of sirtuin genes and Parkinson’s disease
Authors: Silvia Jesús
Pilar Gómez-Garre
Fátima Carrillo
María T. Cáceres-Redondo
Ismael Huertas-Fernández
Inmaculada Bernal-Bernal
Marta Bonilla-Toribio
Laura Vargas-González
Manuel Carballo
Pablo Mir
Publication date: 01-09-2013
Publisher: Springer Berlin Heidelberg
Published in: Journal of Neurology / Issue 9/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-013-6970-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Genetic association of sirtuin genes and Parkinson’s disease

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2013

Handwriting as an objective tool for Parkinson’s disease diagnosis

Sub-threshold cognitive impairment in multiple sclerosis: the association with cognitive reserve

Cerebrovascular hemodynamic changes in multiple sclerosis patients during head-up tilt table test: effect of high-dose intravenous steroid treatment

No evidence for CCVSI in relapsing-remitting multiple sclerosis patients with moderate disability

Cardiac sympathetic function in the patients with amyotrophic lateral sclerosis: analysis using cardiac [123I] MIBG scintigraphy

Neurogenic orthostatic hypotension: pathophysiology, evaluation, and management